Pfizer

Pfizer, one of the world’s largest pharmaceutical companies, is moving closer to a major acquisition valued at around $7.3 billion. The company is reportedly finalizing a deal to buy Metsera, a biotech firm focused on weight-loss drugs and metabolic treatments. This move highlights Pfizer’s ambition to expand into one of the fastest-growing markets in healthcare,…

Pfizer surprised investors with a stellar earnings report this quarter. The pharmaceutical giant posted second-quarter sales of $14.7 billion and earnings per share of $0.51, beating expectations. Despite tariff threats from the Trump administration, the stock market responded well, pushing Pfizer shares up over 4% to $24.58. This news matters because it shows Pfizer thriving…